Restricted accessResearch articleFirst published online 2020-06
A Protocol for the Isolation,Culture,and Cryopreservation of Umbilical Cord-Derived Canine Mesenchymal Stromal Cells: Role of Cell Attachment in Long-Term Maintenance
Mesenchymal stromal cells (MSCs) hold great promise in the field of regenerative medicine due to their ability to create a variable localized anti-inflammatory effect in injuries such as Crohn's disease and osteoarthritis or by incorporation in tissue engineered constructs. Currently, the MSC literature uses rodents for preclinical disease models. There is growing interest in using naturally occurring disease in large animals for modeling human disease. By review of the canine MSCs literature, it appears that canine MSCs can be difficult to maintain in culture for extended passages and this greatly varies between tissue sources, compared with human and rodent MSCs, and limited lifespan is an obstacle for preclinical investigation and therapeutic use. Research using canine MSCs has been focused on cells derived from bone marrow or adipose tissue, and the differences in manufacturing MSCs between laboratories are problematic due to lack of standardization. To address these issues, here, a stepwise process was used to optimize canine MSCs isolation, expansion, and cryopreservation utilizing canine umbilical cord-derived MSCs. The culture protocol utilizes coating of tissue culture surfaces that increases cellular adherence, increases colony-forming units-fibroblast efficiency, and decreases population doubling times. Canine MSCs isolated with our protocol could be maintained longer than published canine MSCs methods before senescing. Our improved cryopreservation protocols produce on average >90% viable MSCs at thaw. These methods enable master-bank and working-bank scenarios for allogeneic MSC testing in naturally occurring disease in dogs.
Get full access to this article
View all access options for this article.
References
1.
FriedensteinAJ, PetrakovaKV, KurolesovaAI and FrolovaGP. (1968). Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation, 6:230–247.
2.
WeissML and TroyerDL. (2006). Stem cells in the umbilical cord. Stem Cell Rev, 2:155–162.
3.
TroyerDL and WeissML. (2008). Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells, 26:591–599.
4.
SmithJR, CromerA and WeissML. (2017). Human umbilical cord mesenchymal stromal cell: isolation, expansion, cryopreservation, and characterization. Curr Protoc Stem Cell Biol, 41:1F.18.1–1F.18.23.
5.
SmithJR, PfeiferK, PetryF, PowellN, DelzeitJ and WeissML. (2016). Standardizing umbilical cord mesenchymal stromal cells for translation to clinical use: selection of GMP-compliant medium and a simplified isolation method. Stem Cells Int, 2016:6810980.
6.
FazzinaR, MariottiA, ProcoliA, FioravantiD, IudiconeP, ScambiaG, PierelliL and BonannoG. (2015). A new standardized clinical-grade protocol for banking human umbilical cord tissue cells. Transfusion, 55:2864–2873.
7.
BadowskiM, MuiseA and HarrisDT. (2014). Mixed effects of long-term frozen storage on cord tissue stem cells. Cytotherapy, 16:1313–1321.
8.
ChatzistamatiouTK, PapassavasAC, MichalopoulosE, GamaloutsosC, MallisP, GontikaI, PanagouliE, KoussoulakosSL and Stavropoulos-GiokasC. (2014). Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank. Transfusion, 54:3108–3120.
GangulyP, El-JawhariJJ, GiannoudisPV, BurskaAN, PonchelF and JonesEA. (2017). Age-related changes in bone mesenchymal stromal cells: a potential impact on osteoporosis and osteoarthritis development. Cell Transplant, 26:1520–1529.
CarlinR, DavisD, WeissM, SchultzB and TroyerD. (2006). Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod Biol Endocrinol, 4:8.
14.
RaoufiMF, TajikP, DehghanMM, EiniF and BarinA. (2011). Isolation and differentiation of mesenchymal stem cells from bovine umbilical cord blood. Reprod Domest Anim, 46:95–99.
15.
KumarK, AgarwalP, DasK, MiliB, MadhusoodanAP, KumarA and BagS. (2016). Isolation and characterization of mesenchymal stem cells from caprine umbilical cord tissue matrix. Tissue Cell, 48:653–658.
16.
CremonesiF, VioliniS, Lange ConsiglioA, RamelliP, RanzenigoG and MarianiP. (2008). Isolation, in vitro culture and characterization of foal umbilical cord stem cells at birth. Vet Res Commun 32 Suppl, 1:S139–S142.
17.
SaulnierN, LoriauJ, FebreM, RobertC, RakicR, BonteT, BuffS and MaddensS. (2016). Canine placenta: a promising potential source of highly proliferative and immunomodulatory mesenchymal stromal cells?. Vet Immunol Immunopathol, 171:47–55.
18.
SeoMS, ParkSB and KangKS. (2012). Isolation and characterization of canine Wharton's jelly-derived mesenchymal stem cells. Cell Transplant, 21:1493–1502.
19.
RyuHH, KangBJ, ParkSS, KimY, SungGJ, WooHM, KimWH and KweonOK. (2012). Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton's jelly, and umbilical cord blood for treating spinal cord injuries in dogs. J Vet Med Sci, 74:1617–1630.
ClarkKC, KolA, ShahbenderianS, GranickJL, WalkerNJ and BorjessonDL. (2016). Canine and equine mesenchymal stem cells grown in serum free media have altered immunophenotype. Stem Cell Rev, 12:245–256.
22.
RussellKA, ChowNH, DukoffD, GibsonTW, LaMarreJ, BettsDH and KochTG. (2016). Characterization and immunomodulatory effects of canine adipose tissue- and bone marrow-derived mesenchymal stromal cells. PLoS One, 11:e0167442.
23.
ViswanathanS, KeatingA, DeansR, HemattiP, ProckopD, StroncekDF, StaceyG, WeissDJ, MasonC and RaoMS. (2014). Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation. Stem Cells Dev, 23:1157–1167.
24.
WeissML, RaoMS, DeansR and CzermakP. (2016). Manufacturing cells for clinical use. Stem Cells Int, 2016:1750697.
25.
BertoloA, SteffenF, Malonzo-MartyC and StoyanovJ. (2015). Canine mesenchymal stem cell potential and the importance of dog breed: Implication for cell-based therapies. Cell Transplant, 24:1969–1980.
26.
de BakkerE, Van RyssenB, De SchauwerC and MeyerE. (2013). Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man. Vet Q, 33:225–233.
27.
BlackLL, GaynorJ, GahringD, AdamsC, AronD, HarmanS, GingerichDA and HarmanR. (2007). Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet Ther, 8:272–284.
28.
GuercioA, Di BellaS, CasellaS, Di MarcoP, RussoC and PiccioneG. (2013). Canine mesenchymal stem cells (MSCs): characterization in relation to donor age and adipose tissue-harvesting site. Cell Biol Int, 37:789–798.
29.
VilarJM, MoralesM, SantanaA, SpinellaG, RubioM, CuervoB, CugatR and CarrilloJM. (2013). Controlled, blinded force platform analysis of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells associated to PRGF-Endoret in osteoarthritic dogs. BMC Vet Res, 9:131.
30.
UpchurchDA, RenbergWC, RoushJK, MillikenGA and WeissML. (2016). Effects of administration of adipose-derived stromal vascular fraction and platelet-rich plasma to dogs with osteoarthritis of the hip joints. Am J Vet Res, 77:940–951.
31.
CabonQ, FebreM, GomezN, CachonT, PillardP, CarozzoC, SaulnierN, RobertC, LivetV, et al. (2019). Long-term safety and efficacy of single or repeated intra-articular injection of allogeneic neonatal mesenchymal stromal cells for managing pain and lameness in moderate to severe canine osteoarthritis without anti-inflammatory pharmacological support: pilot clinical study. Front Vet Sci, 6:10.
32.
SeoMS, JeongYH, ParkJR, ParkSB, RhoKH, KimHS, YuKR, LeeSH, JungJW, LeeYS and KangKS. (2009). Isolation and characterization of canine umbilical cord blood-derived mesenchymal stem cells. J Vet Sci, 10:181–187.
33.
SahooAK, DasJK and NayakS. (2017). Isolation, culture, characterization, and osteogenic differentiation of canine endometrial mesenchymal stem cell. Vet World, 10:1533–1541.
34.
ZucconiE, VieiraNM, BuenoDF, SeccoM, JazedjeT, AmbrosioCE, Passos-BuenoMR, MiglinoMA and ZatzM. (2010). Mesenchymal stem cells derived from canine umbilical cord vein—a novel source for cell therapy studies. Stem Cells Dev, 19:395–402.
35.
DominiciM, Le BlancK, MuellerI, Slaper-CortenbachI, MariniF, KrauseD, DeansR, KeatingA, ProckopD and HorwitzE. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8:315–317.
36.
EscalhaoCCM, RamosIP, Hochman-MendezC, BrunswickTHK, SouzaSAL, GutfilenB, Dos Santos GoldenbergRC and Coelho-SampaioT. (2017). Safety of allogeneic canine adipose tissue-derived mesenchymal stem cell Intraspinal transplantation in dogs with chronic spinal cord injury. Stem Cells Int, 2017:3053759.
37.
TaroniM, CabonQ, FebreM, CachonT, SaulnierN, CarozzoC, MaddensS, LabadieF, RobertC and ViguierE. (2017). Evaluation of the effect of a single intra-articular injection of allogeneic neonatal mesenchymal stromal cells compared to oral non-steroidal anti-inflammatory treatment on the postoperative musculoskeletal status and gait of dogs over a 6-month period after tibial plateau leveling osteotomy: a pilot study. Front Vet Sci, 4:83.
38.
EslaminejadMB and TaghiyarL. (2010). Study of the structure of canine mesenchymal stem cell osteogenic culture. Anat Histol Embryol, 39:446–455.
39.
ChoiSA, ChoiHS, KimKJ, LeeDS, LeeJH, ParkJY, KimEY, LiX, OhHY, LeeDS and KimMK. (2013). Isolation of canine mesenchymal stem cells from amniotic fluid and differentiation into hepatocyte-like cells. In Vitro Cell Dev Biol Anim, 49:42–51.
40.
CsakiC, MatisU, MobasheriA, YeH and ShakibaeiM. (2007). Chondrogenesis, osteogenesis and adipogenesis of canine mesenchymal stem cells: a biochemical, morphological and ultrastructural study. Histochem Cell Biol, 128:507–520.
41.
WhitworthDJ, FrithJE, FrithTJ, OvchinnikovDA, Cooper-WhiteJJ and WolvetangEJ. (2014). Derivation of mesenchymal stromal cells from canine induced pluripotent stem cells by inhibition of the TGFbeta/activin signaling pathway. Stem Cells Dev, 23:3021–3033.
42.
VieiraNM, BrandaliseV, ZucconiE, SeccoM, StraussBE and ZatzM. (2010). Isolation, characterization, and differentiation potential of canine adipose-derived stem cells. Cell Transplant, 19:279–289.
43.
Perez-MerinoEM, Uson-CasausJM, Zaragoza-BayleC, Duque-CarrascoJ, Marinas-PardoL, Hermida-PrietoM, Barrera-ChaconR and GualtieriM. (2015). Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: clinical and laboratory outcomes. Vet J, 206:385–390.
44.
KisielAH, McDuffeeLA, MasaoudE, BaileyTR, Esparza GonzalezBP and Nino-FongR. (2012). Isolation, characterization, and in vitro proliferation of canine mesenchymal stem cells derived from bone marrow, adipose tissue, muscle, and periosteum. Am J Vet Res, 73:1305–1317.
45.
TakemitsuH, ZhaoD, YamamotoI, HaradaY, MichishitaM and AraiT. (2012). Comparison of bone marrow and adipose tissue-derived canine mesenchymal stem cells. BMC Vet Res, 8:150.
46.
ChowL, JohnsonV, CoyJ, ReganD and DowS. (2017). Mechanisms of immune suppression utilized by canine adipose and bone marrow-derived mesenchymal stem cells. Stem Cells Dev, 26:374–389.
47.
HongJ, HeH, BuiP, Ryba-WhiteB, RumiMA, SoaresMJ, DuttaD, PaulS, KawamataM, et al. (2013). A focused microarray for screening rat embryonic stem cell lines. Stem Cells Dev, 22:431–443.
48.
KobayashiK, IchiharaY, SatoN, UmedaN, FieldsL, FukumitsuM, TagoY, ItoT, KainumaS, et al. (2019). On-site fabrication of Bi-layered adhesive mesenchymal stromal cell-dressings for the treatment of heart failure. Biomaterials, 209:41–53.
49.
CarrionB, JansonIA, KongYP and PutnamAJ. (2014). A safe and efficient method to retrieve mesenchymal stem cells from three-dimensional fibrin gels. Tissue Eng Part C Methods, 20:252–263.
50.
NawrockaD, KornickaK, SzydlarskaJ and MaryczK. (2017). Basic fibroblast growth factor inhibits apoptosis and promotes proliferation of adipose-derived mesenchymal stromal cells isolated from patients with type 2 diabetes by reducing cellular oxidative stress. Oxid Med Cell Longev, 2017:3027109.
51.
ColenciR, da Silva AssuncaoLR, Mogami BomfimSR, de Assis GolimM, DeffuneE and Penha OliveiraSH. (2014). Bone marrow mesenchymal stem cells stimulated by bFGF up-regulated protein expression in comparison with periodontal fibroblasts in vitro. Arch Oral Biol, 59:268–276.
52.
FierroFA, KalomoirisS, SondergaardCS and NoltaJA. (2011). Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells, 29:1727–1737.
53.
SeshareddyK, TroyerD and WeissML. (2008). Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord. Methods Cell Biol, 86:101–119.
54.
DevireddyLR, MyersM, ScrevenR, LiuZ and BoxerL. (2019). A serum-free medium formulation efficiently supports isolation and propagation of canine adipose-derived mesenchymal stem/stromal cells. PLoS One, 14:e0210250.
55.
AlvesEG, SerakidesR, BoeloniJN, RosadoIR, OcarinoNM, OliveiraHP, GoesAM and RezendeCM. (2014). Comparison of the osteogenic potential of mesenchymal stem cells from the bone marrow and adipose tissue of young dogs. BMC Vet Res, 10:190.
56.
Ayala-CuellarAP, KimCW, HwangKA, KangJH, LeeG, ChoJ and ChoiKC. (2019). Characterization of canine adipose tissue-derived mesenchymal stem cells immortalized by SV40-T retrovirus for therapeutic use. J Cell Physiol, 234:16630–16642.
57.
BeardenRN, HugginsSS, CummingsKJ, SmithR, GregoryCA and SaundersWB. (2017). In-vitro characterization of canine multipotent stromal cells isolated from synovium, bone marrow, and adipose tissue: a donor-matched comparative study. Stem Cell Res Ther, 8:218.
58.
GardinC, FerroniL, BellinG, RubiniG, BarosioS and ZavanB. (2018). Therapeutic potential of autologous adipose-derived stem cells for the treatment of liver disease. Int J Mol Sci 19:pii:. E4064.
LiuZ, ScrevenR, BoxerL, MyersMJ and DevireddyLR. (2018). Characterization of canine adipose-derived mesenchymal stromal/stem cells in serum-free medium. Tissue Eng Part C Methods, 24:399–411.
61.
MielcarekM, StorbR, GeorgesGE, GolubevL, NikitineA, HwangB, NashRA and Torok-StorbB. (2011). Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation. Biol Blood Marrow Transplant, 17:214–225.
62.
Rodriguez SanchezDN, de Lima ResendeLA, Boff Araujo PintoG, de Carvalho BovolatoAL, PossebonFS, DeffuneE and AmorimRM. (2019). Canine adipose-derived mesenchymal stromal cells enhance neuroregeneration in a rat model of sciatic nerve crush injury. Cell Transplant, 28:47–54.
63.
RyuHH, LimJH, ByeonYE, ParkJR, SeoMS, LeeYW, KimWH, KangKS and KweonOK. (2009). Functional recovery and neural differentiation after transplantation of allogenic adipose-derived stem cells in a canine model of acute spinal cord injury. J Vet Sci, 10:273–284.
64.
SasakiA, MizunoM, OzekiN, KatanoH, OtabeK, TsujiK, KogaH, MochizukiM and SekiyaI. (2018). Canine mesenchymal stem cells from synovium have a higher chondrogenic potential than those from infrapatellar fat pad, adipose tissue, and bone marrow. PLoS One, 13:e0202922.
65.
WoodJA, ChungDJ, ParkSA, ZwingenbergerAL, ReillyCM, LyI, WalkerNJ, VernauW, HayashiK, et al. (2012). Periocular and intra-articular injection of canine adipose-derived mesenchymal stem cells: an in vivo imaging and migration study. J Ocul Pharmacol Ther, 28:307–317.
66.
WangT, YangX, QiX and JiangC. (2015). Osteoinduction and proliferation of bone-marrow stromal cells in three-dimensional poly (epsilon-caprolactone)/hydroxyapatite/collagen scaffolds. J Transl Med, 13:152.
67.
TanGK, DinnesDL, MyersPT and Cooper-WhiteJJ. (2011). Effects of biomimetic surfaces and oxygen tension on redifferentiation of passaged human fibrochondrocytes in 2D and 3D cultures. Biomaterials, 32:5600–5614.
68.
SpencerAY and LallierTE. (2009). Mechanical tension alters semaphorin expression in the periodontium. J Periodontol, 80:1665–1673.
69.
OlsenTR, NgKS, LockLT, AhsanT and RowleyJA. (2018). Peak MSC-are we there yet?. Front Med (Lausanne), 5:178.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
